Medical Stocks

J&J Knew About Hip Implant Problems

Documents unsealed by a California court indicate that Johnson & Johnson knew about defective hip implants two years before it recalled them. More 

Surprise! Dendreon Doesn’t Stink Anymore

It took three years, but this biotech may be quietly finding its footing as its innovative Provenge prostate-cancer fighter gains credibility. More 

Stryker Provides a Long-Standing Dividend Story

Stryker together with its subsidiaries, operates as a medical technology company. The company has a steady 20-year history as a dividend payer. More 

Becton Dickinson Dividends Look Safe and Steady

Becton, Dickinson a medical technology company, develops, manufactures, and sells medical devices is a steady dividend player with long-term growth potential More 

Hospital Stocks Set for Good, Not Great, 2013

Further gains are possible, but not like 2012's terrific performance. Political uncertainty over Medicaid cuts will most likely make for a volatile ride. More 

Disney Inks Deal With Cox Communications

Cox Communications has signed a multi-year deal with Disney to provide subscribers with affiliate and video streaming services. More 

Effective Alzheimer’s Drugs May Be Just Three Years Away

New research, both by scientists and the big drug companies, is leading to increased hope for sufferers of Alzheimer's disease. More